| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 11/20/2002 | EP1257286A2 Cancer treatment and prognosis involving hes-1 protein |
| 11/20/2002 | EP1257285A2 Use of breast cancer associated membrane proteins (bcmp) for treatment, prophylaxis and diagnosis of breast cancer |
| 11/20/2002 | EP1257282A1 Pancreatic stem cells and their use in transplantation |
| 11/20/2002 | EP1257281A1 Nucleoside analogs with carboxamidine modified monocyclic base |
| 11/20/2002 | EP1257280A1 Drospirenone for hormone replacement therapy |
| 11/20/2002 | EP1257279A2 Improvement of implantation rate using ff-mas |
| 11/20/2002 | EP1257278A1 The use of mirtazapine for the treatment of sleep disorders |
| 11/20/2002 | EP1257277A2 New drug combinations comprising a norepinephrine reuptake inhibitor and an antimuscarinic agent |
| 11/20/2002 | EP1257276A1 Antiviral azaindole derivatives |
| 11/20/2002 | EP1257275A2 Use of central cannabinoid receptor antagonist for preparing medicines designed to facilitate smoking cessation |
| 11/20/2002 | EP1257274A2 Use of 2-methyl-thiazolidin-2,4-dicarboxylic acid for treating infectious diseases |
| 11/20/2002 | EP1257273A2 Improved treatment for acute physical insult to the central nervous system |
| 11/20/2002 | EP1257272A1 Thiazolium compounds and treatments of disorders associated with protein aging |
| 11/20/2002 | EP1257271A1 Use of pramipexole for the treatment of addictive disorders |
| 11/20/2002 | EP1257270A1 A method for synthesizing leflunomide |
| 11/20/2002 | EP1257269A1 Orally administrable acid stable anti-ulcer benzimidazole derivatives |
| 11/20/2002 | EP1257268A2 Diagnostic and therapeutic compositions and methods for affecting tumor growth using oxygen mimetic agents |
| 11/20/2002 | EP1257267A1 Composition for the prevention and/or treatment of lipid metabolism disorders and allergic forms |
| 11/20/2002 | EP1257266A1 Intravenous carnitine for the treatment of chronic uraemic patients undergoing periodical dialysis |
| 11/20/2002 | EP1257265A2 Use of 2-phenylene diamine derivatives for the treatment of infections |
| 11/20/2002 | EP1257264A1 Estrogen receptor modulators |
| 11/20/2002 | EP1257262A2 Pharmacological agent comprising picolinic acid, fusaric acid and derivatives thereof |
| 11/20/2002 | EP1257261A2 Antiviral pharmaceutical compositions containing iron chelators |
| 11/20/2002 | EP1257260A1 Powder formulation for inhalation |
| 11/20/2002 | EP1257255A1 Therapeutic product, use and formulation thereof |
| 11/20/2002 | EP1257254A2 Formulations containing an anticholinergic drug for the treatment of chronic obstructive pulmonary disease |
| 11/20/2002 | EP1257248A1 Pharmaceutical composition |
| 11/20/2002 | EP1257245A2 Protection of the female reproductive system from natural and artificial insults |
| 11/20/2002 | EP1187832B1 Amino heterocycles useful as pharmaceutical agents |
| 11/20/2002 | EP1165472A4 Methods for the preparation of biphenyl isoxazole sulfonamides |
| 11/20/2002 | EP1163259B1 14.beta.,17-alpha-hydroxymethylandrostane derivatives as androgens |
| 11/20/2002 | EP1150969B1 Alpha-azacyclomethyl quinoline derivatives for treating urinary incontinence |
| 11/20/2002 | EP1147101B1 Reverse hydroxamate inhibitors of matrix metalloproteinases |
| 11/20/2002 | EP1140190B1 Combinations of ileal bile acid transport inhibitors and bile acid sequestering agents for cardiovascular indications |
| 11/20/2002 | EP1107732B1 Oral liquid mucoadhesive compositions |
| 11/20/2002 | EP1100539B1 Combination of active substances, especially for the prophylaxis and therapy of ischaemic organic lesions and reperfusion syndromes |
| 11/20/2002 | EP1098645B1 Compositions comprising phenylaminothiophenacetic acid derivatives for the treatment of acute or adult respiratory distress syndrome (ards) and infant respiratory distress syndrome (irds) |
| 11/20/2002 | EP1077966B1 Biphenyl sulfonyl aryl carboxylic acids useful in the treatment of insulin resistance and hyperglycemia |
| 11/20/2002 | EP1073472B1 Solution containing an ester of ala for diagnosing or treating tissue pathologies |
| 11/20/2002 | EP1054666B1 Liquid pharmaceutical formulation containing zotepine |
| 11/20/2002 | EP1047688B1 Thiophene nitrone compounds |
| 11/20/2002 | EP1042301B1 Novel acylguanidine derivatives as inhibitors of bone resorption and as vitronectin receptor antagonists |
| 11/20/2002 | EP1042285A4 iso-CBI AND iso-CI ANALOGS OF CC-1065 AND THE DUOCARMYCINS |
| 11/20/2002 | EP1033984B1 Concentrate for medical solution and use thereof |
| 11/20/2002 | EP1007522B1 2- 4-[4-(4,5-dichloro-2-methylimidazol-1-yl)butyl]piperazin-1-yl -5-fluoropyrimidine, its preparation and therapeutic use |
| 11/20/2002 | EP1003525B1 Composition and method for regulating cell proliferation and cell death |
| 11/20/2002 | EP1001758B1 Method of screening of potential drugs against obesity, capable of modulating the regulation of ucp-2 |
| 11/20/2002 | EP0984952B1 A new salt |
| 11/20/2002 | EP0984784B1 Anti-cancer products for treating cystic fibrosis |
| 11/20/2002 | EP0954337B1 Intestinal absorption of nicotine to treat nicotine responsive conditions |
| 11/20/2002 | EP0936897B1 Composition having tanning and sun-screening activity, and cosmetic uses thereof |
| 11/20/2002 | EP0935469B1 Use of growth hormone |
| 11/20/2002 | EP0929530B1 Quinazoline derivatives and pharmaceutical compositions containing them |
| 11/20/2002 | EP0920422B1 Crytalline form of 4-[5-methyl-3-phenylisoxazol-4-yl]benzenesulfonamide |
| 11/20/2002 | EP0917465B1 Antimalarial and anti-babesiosis agents and pharmaceutical compositions containing the same agents |
| 11/20/2002 | EP0912568B1 imidazopyridines |
| 11/20/2002 | EP0892780B1 M-AMIDINO PHENYL ANALOGS AS FACTOR Xa INHIBITORS |
| 11/20/2002 | EP0882049B1 Possibly substituted 8-cyano-1-cyclopropyl-7-(2,8-diazabicyclo- 4.3.0]-nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolin carboxylic acids and their derivatives |
| 11/20/2002 | EP0879050B1 Captopril tablets |
| 11/20/2002 | EP0871458B1 Method of decreasing radiation or radio-mimetic chemotherapy for hematopoietic pluripotent cell engraftment |
| 11/20/2002 | EP0868174B1 Oral gel capsule formulation of 1,2,4-benzotriazine oxides |
| 11/20/2002 | EP0845992B1 Use of relaxin for promoting angiogenesis |
| 11/20/2002 | EP0833828B1 Rapamycin derivatives |
| 11/20/2002 | EP0831851B1 Use of pseudopterosins for promoting wound healing |
| 11/20/2002 | EP0826673B1 Acetamide derivatives, process for producing the same, and medicinal composition containing the same |
| 11/20/2002 | EP0814840B1 Oral pharmaceutical dosage forms comprising a proton pump inhibitor and a prokinetic agent |
| 11/20/2002 | EP0813424B1 Oral pharmaceutical dosage forms comprising a proton pump inhibitor and an antacid agent or alginate |
| 11/20/2002 | EP0776325B1 Novel use and novel derivatives of imidazole, method for preparing same, novel intermediates thus obtained, medicinal applications of same and pharmaceutical compositions containing same |
| 11/20/2002 | EP0752865B1 Use of substituted dextrane for treating nervous system damage, and heparane sulphate-enriched fractions |
| 11/20/2002 | EP0750507B1 Proteasome regulation of nf-kappa-b activity |
| 11/20/2002 | EP0699199B1 Heteroatom substituted alkyl benzylaminoquinuclidines as substance p antagonists |
| 11/20/2002 | EP0656360B1 Trifluoromethylpyrroloindole carboxylic ester derivative and process for producing the same |
| 11/20/2002 | EP0593603B1 Bicyclic fibrinogen antagonists |
| 11/20/2002 | EP0572549B1 Use of topotecan in the treatment of non-small cell lung carcinoma |
| 11/20/2002 | EP0547151B1 Treatment process for promoting weight loss employing a substituted delta 5-androstene |
| 11/20/2002 | CN1380885A Alginate having low molecular weight, method of manufacturing it and its use |
| 11/20/2002 | CN1380883A Novel derivatives and analogues of galanthamin |
| 11/20/2002 | CN1380882A C10 ester substituted taxanes as antitumor agents |
| 11/20/2002 | CN1380830A Patch containing 4-biphenylacetic acid |
| 11/20/2002 | CN1380813A Primary composition containing lipophilic bioactive compound |
| 11/20/2002 | CN1380300A Deoxyribozymeoligonucleotide structure for inhibiting telomerase activity and its application |
| 11/20/2002 | CN1380298A Method for separating and extracting total flavone from goldenrain tree plant and its application |
| 11/20/2002 | CN1380289A Amide capable of inhibiting ApoB-secretion/MTP |
| 11/20/2002 | CN1380287A 2-acryl-3-substituted indoacetamide derivative and its medical application |
| 11/20/2002 | CN1380279A (4-alkynyl), aromatic keto-acid compound, synthesis method and its application |
| 11/20/2002 | CN1380094A Achillea total flavone capsule |
| 11/20/2002 | CN1380092A Zhiyusan powder for curing hemorrhoid |
| 11/20/2002 | CN1380084A Medicine for external application for curing diseases of digestive tract, repercussion and stopping pain and its preparation method |
| 11/20/2002 | CN1380083A Formula of injection for relieving pain and its preparation method |
| 11/20/2002 | CN1380077A Programming cell lethal revellent |
| 11/20/2002 | CN1380067A Medicine with functions of reducing sugar and reducing blood-fat and its preparation method |
| 11/20/2002 | CN1380064A Method for producing antibiotic preparation and its application |
| 11/20/2002 | CN1380063A Method for preventing and curing skid aging |
| 11/20/2002 | CN1380062A Saline medicine containing active adjuvant and complex medicine |
| 11/20/2002 | CN1380061A Transdermal preparation for curing male sexual disorder and its preparation method |
| 11/20/2002 | CN1380060A Solution type spray of antimycotic medicine for external application and its preparation method |
| 11/20/2002 | CN1380059A Application of petroselinum sativum extract B in preparation of medicine for preventing and curing ischemic cerebral apoplexy |
| 11/20/2002 | CN1380058A Medicine for promoting synthesis of human self-body EPA and DHA |
| 11/20/2002 | CN1380057A New application of ketamine, its preparation and new method for application |
| 11/20/2002 | CN1380056A Preparation method of high-content oil-soluble vitamin slow-releasing microcapsule powder |